A comprehensive 2026 guide to UK online casinos with a 400% bonus. Understand wagering, find the best offers, and see if a 4x match is actually worth it. Read our full guide to 400% casino bonuses
Malaysian Genomics Inks Agreement in Expansion to Bangladesh
Group to cooperate with Toticell to distribute its products and service Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced a strategic cooperation…
Malaysian Genomics Sees Rise in Profit Margins for 1Q
Group seeks investment opportunities to expand reach of products and services Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today reported a revenue of RM3.81 million for…
Malaysian Genomics Signs Strategic Collaboration Agreement for Expansion in the UAE
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced the signing of a Strategic Collaboration Agreement (SCA) outlining partnerships to market and distribute…
Malaysian Genomics Signs Agreement with National Institutes of Health to Explore Research Opportunities
Both parties to collaborate on research in genomics and biopharmaceuticals MGRC Therapeutics Sdn Bhd (MGRC-T), a wholly-owned subsidiary of Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics…
Malaysian Genomics Grows Presence in Thailand
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce today a series of collaborations to grow its customer base in Thailand…
Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah
Parties agree to collaborate on research in genetics, regenerative and alternative medicine Leading genomics and biopharmaceutical specialist Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155) is pleased to report that…
Malaysian Genomics Reports RM28.36 Million Full-Year Revenue
Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, reported revenue of RM6.33 million for the fourth quarter ended 30 June 2022 (4Q 2022) compared with the loss…
Malaysian Genomics Signs MoU with Ajlan to explore distribution of biopharmaceutical and genetic screening services in MENA region
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced that the Group has signed a Memorandum of Understanding (MoU) to explore opportunities for…
Malaysian Genomics Explores Strategic Partnership with MAHSA Health through MoU
Parties to look for collaborations in practice-based education, research and knowledge exchange and R&D Malaysian Genomics Resource Centre Berhad‘s (Bursa: MGRC, 0155) wholly-owned subsidiary, MGRC Therapeutics Sdn. Bhd. signed a…
Malaysian Genomics Appoints New Chairman
Former MOH Secretary General Dato’ Seri Dr Chen Chaw Min takes over effective 15 July 2022 Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist,…
Malaysian Genomics Forms Partnership for Expansion in Saudi Arabia
Group to collaborate with United Doctors Hospital for genetic screening tests and cell therapies Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today…
Malaysian Genomics Proposes Private Placement
Group to use proceeds for future viable investment and purchase of equipment Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the…
Malaysian Genomics to Offer First-Ever Sports-Based Tests Specific to Southeast Asian Genetic Profiles
The Group is collaborating with Rinani Genotec to develop and offer genetic screening tests catering to athletes and those with active lifestyles Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155),…